Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | OCEL | Common Stock | Other | -15M | -8.99% | 152M | Oct 29, 2021 | Direct | F1, F2 | ||
transaction | OCEL | Common Stock | Other | +15M | +9.88% | 167M | Oct 29, 2021 | Direct | F1, F2 | ||
holding | OCEL | Common Stock | 117M | Oct 29, 2021 | Additional shares held by spouse | F3 |
Id | Content |
---|---|
F1 | The shares of common stock of Organicell Regenerative Medicine, Inc., a Nevada corporation (the "Company") were disposed of and acquired, respectively, pursuant to an Exchange Agreement dated October 29, 2021 (the "Agreement"), whereby the Reporting Person exchanged shares of common stock of the Company previously issued under the Organicell Regenerative Medicine, Inc. Management and Consultants Performance Stock Plan for shares of common stock of the Company in the Organicell Regenerative Medicine, Inc. 2021 Equity Incentive Plan. The newly issued shares shall vest on December 31, 2023. |
F2 | Received in exchange for the Company's common stock on a 1:1 basis. This exchange was completed in connection with the Agreement. |
F3 | The total number of shares of common stock owned collectively by Maria Ines Mitrani and Albert Mitrani is 283,498,080. |